These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7594097)

  • 1. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.
    Rupprecht HJ; Terres W; Ozbek C; Luz M; Jessel A; Hafner G; vom Dahl J; Kromer EP; Prellwitz W; Meyer J
    J Am Coll Cardiol; 1995 Dec; 26(7):1637-42. PubMed ID: 7594097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
    Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
    N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.
    Serruys PW; Herrman JP; Simon R; Rutsch W; Bode C; Laarman GJ; van Dijk R; van den Bos AA; Umans VA; Fox KA
    N Engl J Med; 1995 Sep; 333(12):757-63. PubMed ID: 7643882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
    Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
    Yusuf S
    Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
    Bittl JA; Ahmed WH
    Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
    Roe MT; Granger CB; Puma JA; Hellkamp AS; Hochman JS; Ohman EM; White HD; Van de Werf F; Armstrong PW; Ellis SG; Califf RM; Topol EJ
    Am J Cardiol; 2001 Dec; 88(12):1403-6, A6. PubMed ID: 11741559
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators.
    Bittl JA; Feit F
    Am J Cardiol; 1998 Oct; 82(8B):43P-49P. PubMed ID: 9809891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
    van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
    Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty.
    Cannon CP; Braunwald E
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):30S-37S. PubMed ID: 7775712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.
    Circulation; 1997 Aug; 96(3):769-77. PubMed ID: 9264481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study.
    Bittl JA; Chaitman BR; Feit F; Kimball W; Topol EJ
    Am Heart J; 2001 Dec; 142(6):952-9. PubMed ID: 11717596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions.
    Shah PB; Ahmed WH; Ganz P; Bittl JA
    J Am Coll Cardiol; 1997 Nov; 30(5):1264-9. PubMed ID: 9350925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ill wind of transient vessel closure during percutaneous transluminal coronary angioplasty.
    Block PC
    J Am Coll Cardiol; 1999 Jan; 33(1):79-81. PubMed ID: 9935012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.